Top

Gepubliceerd in:

06-06-2020 | Review

Health-related quality of life overview after different curative treatment options in muscle-invasive bladder cancer: an umbrella review

Auteurs: Elke Rammant, Lisa Van Wilder, Mieke Van Hemelrijck, Nele S. Pauwels, Karel Decaestecker, Charles Van Praet, Renée Bultijnck, Piet Ost, Thomas Van Vaerenbergh, Sofie Verhaeghe, Ann Van Hecke, Valérie Fonteyne

Gepubliceerd in: Quality of Life Research | Uitgave 11/2020

Abstract

Purpose

This umbrella review aims to evaluate the quality, summarize and compare the conclusions of systematic reviews investigating the impact of curative treatment options on health-related quality of life (HRQoL) in muscle-invasive bladder cancer (MIBC).

Methods

The Cochrane Library, MEDLINE, Embase and Web of Science were searched independently by two authors from inception until 06 January 2020. Systematic reviews and meta-analyses assessing the impact of any curative treatment option on HRQol in MIBC patients were eligible. Risk of bias was assessed using the AMSTAR 2 tool.

Results

Thirty-two reviews were included. Robot-assisted RC with extracorporeal urinary diversion and open RC have similar HRQoL (n = 10). Evidence for pelvic organ-sparing RC was too limited (n = 2). Patients with a neobladder showed better overall and physical HRQoL outcomes, but worse urinary function in comparison with ileal conduit (n = 17). Bladder-preserving radiochemotherapy showed slightly better urinary and sexual but worse gastro-intestinal HRQoL outcomes in comparison with RC patients (n = 6). Quality of the reviews was low in more than 50% of the available reviews and most of the studies included in the reviews were nonrandomized studies.

Conclusion

This umbrella review gives a comprehensive overview of the available evidence to date.

vorige artikel Measurement properties of preference-based measures for economic evaluation in COPD: a systematic review

volgende artikel Exploring health-related quality of life and frailty in older adults based on the Korean Frailty and Aging Cohort Study

Alleen toegankelijk voor geautoriseerde gebruikers

Witjes, J. A., Lebret, T., Compérat, E. M., Cowan, N. C., De Santis, M., Bruins, H. M., et al. (2017). Updated 2016 EAU guidelines on muscle-invasive and metastatic bladder cancer. European Urology, 71(3), 462–475.CrossRef

Stenzl, A., Witjes, J., Compérat, E., Cowan, N., De Santis, M., Kuczyk, M., et al. (2012). Bladder Cancer Muscle-invasive and metastatic. European Urology, 65(4), 778–792. https://doi.org/10.1016/j.eururo.2013.11.046.CrossRef

Van Rhijn, B. W., Burger, M., Lotan, Y., Solsona, E., Stief, C. G., Sylvester, R. J., et al. (2009). Recurrence and progression of disease in non–muscle-invasive bladder cancer: from epidemiology to treatment strategy. European Urology, 56(3), 430–442.CrossRef

Mahdavifar, N., Ghoncheh, M., Pakzad, R., Momenimovahed, Z., & Salehiniya, H. (2016). Epidemiology, incidence and mortality of bladder cancer and their relationship with the development index in the world. Asian Pacific Journal of Cancer Prevention, 17(1), 381–386.CrossRef

Galsky, M. D., Diefenbach, M., Mohamed, N., Baker, C., Pokhriya, S., Rogers, J., et al. (2017). Web-based tool to facilitate shared decision making with regard to neoadjuvant chemotherapy use in muscle-invasive bladder cancer. JCO Clinical Cancer Informatics, 1, 1–12.

Davis, R. B., Farber, N. J., Tabakin, A. L., Kim, I. Y., & Elsamra, S. E. (2016). Open versus robotic cystectomy: Comparison of outcomes. Investigative and Clinical Urology, 57(Suppl 1), S36–43. https://doi.org/10.4111/icu.2016.57.S1.S36.CrossRef

Hu, J. C., Gu, X., Lipsitz, S. R., Barry, M. J., D’Amico, A. V., Weinberg, A. C., et al. (2009). Comparative effectiveness of minimally invasive vs open radical prostatectomy. JAMA, 302(14), 1557–1564.CrossRef

Schwenk, W., Haase, O., Neudecker, J. J., & Müller, J. M. J. C. (2005). Short term benefits for laparoscopic colorectal resection. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.CD003145.pub2.CrossRef

Zaghloul, M. S., Christodouleas, J. P., Smith, A., Abdallah, A., William, H., Khaled, H. M., et al. (2018). Adjuvant sandwich chemotherapy plus radiotherapy vs adjuvant chemotherapy alone for locally advanced bladder cancer after radical cystectomy: a randomized phase 2 trial. JAMA Surgery, 153(1), e174591–e174591.CrossRef

10.

Nygren, J., Ljungqvist, O., & Thorell, A. (2017). Enhanced recovery after surgery: ERAS. Surgical Patient Care (pp. 349–361). Cham: Springer.CrossRef

11.

Kulkarni, G. S., Hermanns, T., Wei, Y., Bhindi, B., Satkunasivam, R., Athanasopoulos, P., et al. (2017). Propensity score analysis of radical cystectomy versus bladder-sparing trimodal therapy in the setting of a multidisciplinary bladder cancer clinic. Journal of Clinical Oncology, 35(20), 2299–2305.CrossRef

12.

Glatzer, M., Panje, C. M., Sirén, C., Cihoric, N., & Putora, P. M. (2018). Decision making criteria in oncology. Oncology, 98(6), 39–47.

13.

Berry, D. L., Nayak, M., Halpenny, B., Harrington, S., Loughlin, K. R., Chang, P., et al. (2015). Treatment decision making in patients with bladder cancer. Bladder Cancer, 1(2), 151–158. https://doi.org/10.3233/blc-150029.CrossRef

14.

Mohamed, N. E., Gilbert, F., Lee, C. T., Sfakianos, J., Knauer, C., Mehrazin, R., et al. (2016). Pursuing quality in the application of bladder cancer quality of life research. Bladder Cancer, 2(2), 139–149. https://doi.org/10.3233/blc-160051.CrossRef

15.

Wright, J. L., & Porter, M. P. (2007). Quality-of-life assessment in patients with bladder cancer. Nat Clin Pract Urol, 4(3), 147–154. https://doi.org/10.1038/ncpuro0750.CrossRef

16.

Mason, S. J., Catto, J. W., Downing, A., Bottomley, S. E., Glaser, A. W., & Wright, P. (2018). Evaluating patient-reported outcome measures (PROM s) for bladder cancer: a systematic review using the CO nsensus-based Standards for the selection of health Measurement INstruments (COSMIN) checklist. BJU International, 122(5), 760–773.CrossRef

17.

Tamburini, M. (2001). Health-related quality of life measures in cancer. Annals of Oncology, 12(suppl_3), S7–S10.CrossRef

18.

Aromataris, E., Fernandez, R., Godfrey, C. M., Holly, C., Khalil, H., & Tungpunkom, P. (2015). Summarizing systematic reviews: methodological development, conduct and reporting of an umbrella review approach. International Journal of Evidence-Based Healthcare, 13(3), 132–140.CrossRef

19.

Shea, B. J., Reeves, B. C., Wells, G., Thuku, M., Hamel, C., Moran, J., et al. (2017). AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ, 358, j4008.CrossRef

20.

Botteman, M. F., Pashos, C. L., Hauser, R. S., Laskin, B. L., & Redaelli, A. (2003). Quality of life aspects of bladder cancer: A review of the literature. Quality of Life Research, 12(6), 675–688. https://doi.org/10.1023/A:1025144617752.CrossRef

21.

Parkinson, J. P., & Konety, B. R. (2004). Health related quality of life assessments for patients with bladder cancer. Journal of Urology, 172(6 I), 2130–2136. https://doi.org/10.1097/01.ju.0000139445.49500.24.CrossRef

22.

Gerharz, E. W., Mansson, A., Hunt, S., Skinner, E. C., & Mansson, W. (2005). Quality of life after cystectomy and urinary diversion: An evidence based analysis. Journal of Urology, 174(5), 1729–1736. https://doi.org/10.1097/01.ju.000176463.40530.05.CrossRef

23.

Porter, M. P., & Penson, D. F. (2005). Health related quality of life after radical cystectomy and urinary diversion for bladder cancer: A systematic review and critical analysis of the literature. Journal of Urology, 173(4), 1318–1322. https://doi.org/10.1097/01.ju.0000149080.82697.65.CrossRef

24.

Somani, B. K., Gimlin, D., Fayers, P., & N'Dow, J. (2009). Quality of life and body image for bladder cancer patients undergoing radical cystectomy and urinary diversion-A prospective cohort study with a systematic review of literature. Urology, 74(5), 1138–1143. https://doi.org/10.1016/j.urology.2009.05.087.CrossRef

25.

Kassouf, W., Hautmann, R. E., Bochner, B. H., Lerner, S. P., Colombo, R., Zlotta, A., et al. (2010). A critical analysis of orthotopic bladder substitutes in adult patients with bladder cancer: Is there a perfect solution? European Urology, 58(3), 374–383. https://doi.org/10.1016/j.eururo.2010.05.023.CrossRef

26.

Hautmann, R. E., Abol-Enein, H., Davidsson, T., Gudjonsson, S., Hautmann, S. H., Holm, H. V., et al. (2013). ICUD-EAU international consultation on bladder cancer 2012: Urinary diversion. European Urology, 63(1), 67–80. https://doi.org/10.1016/j.eururo.2012.08.050.CrossRef

27.

Perlis, N., Krahn, M., Alibhai, S., Finelli, A., Ritvo, P., Bremner, K. E., et al. (2014). Conceptualizing global health-related quality of life in bladder cancer. Quality of Life Research: An International Journal of quality of Life Aspects of Treatment, Care and Rehabilitation, 23(8), 2153–2167. https://doi.org/10.1007/s11136-014-0685-9.CrossRef

28.

Ali, A. S., Hayes, M. C., Birch, B., Dudderidge, T., & Somani, B. K. (2015). Health related quality of life (HRQoL) after cystectomy: Comparison between orthotopic neobladder and ileal conduit diversion. European Journal of Surgical Oncology, 41(3), 295–299. https://doi.org/10.1016/j.ejso.2014.05.006.CrossRef

29.

Cerruto, M. A., D'Elia, C., Siracusano, S., Gedeshi, X., Mariotto, A., Iafrate, M., et al. (2016). Systematic review and meta-analysis of non RCT's on health related quality of life after radical cystectomy using validated questionnaires: Better results with orthotopic neobladder versus ileal conduit. European Journal of Surgical Oncology, 42(3), 343–360. https://doi.org/10.1016/j.ejso.2015.10.001.CrossRef

30.

Crozier, J., Hennessey, D., Sengupta, S., Bolton, D., & Lawrentschuk, N. (2016). A Systematic review of ileal conduit and neobladder outcomes in primary bladder cancer. Urology, 96, 74–79. https://doi.org/10.1016/j.urology.2016.06.034.CrossRef

31.

Ghosh, A., & Somani, B. (2016). Recent trends in post-cystectomy health-related quality of life (QOL) favours neobladder diversion: Systematic review of the literature. Journal of Urology, 195(4), e751.

32.

Yang, L. S., Shan, B. L., Shan, L. L., Chin, P., Murray, S., Ahmadi, N., et al. (2016). A systematic review and meta-analysis of quality of life outcomes after radical cystectomy for bladder cancer. Surgical Oncology, 25(3), 281–297. https://doi.org/10.1016/j.suronc.2016.05.027.CrossRef

33.

Cerruto, M. A., D'Elia, C., Siracusano, S., Porcaro, A. B., Cacciamani, G., De Marchi, D., et al. (2017). Is health-related quality of life after radical cystectomy using validated questionnaires really better in patients with ileal orthotopic neobladder compared to ileal conduit: A meta-analysis of retrospective comparative studies. Current Urology, 10(2), 57–68. https://doi.org/10.1159/000447153.CrossRef

34.

Smith, A. B., Crowell, K., Woods, M. E., Wallen, E. M., Pruthi, R. S., Nielsen, M. E., et al. (2017). Functional outcomes following radical cystectomy in women with bladder cancer: A systematic review. European Urology Focus, 3(1), 136–143. https://doi.org/10.1016/j.euf.2016.05.005.CrossRef

35.

Zahran, M. H., Fahmy, O., Ei-Hefnawy, A. S., & Ali-El-Dein, B. (2016). Female sexual dysfunction post radical cystectomy and urinary diversion. Climacteric, 19(6), 546–550. https://doi.org/10.1080/13697137.2016.1225714.CrossRef

36.

Veskimae, E., Neuzillet, Y., Rouanne, M., MacLennan, S., Lam, T. B. L., Yuan, Y. H., et al. (2017). Systematic review of the oncological and functional outcomes of pelvic organ-preserving radical cystectomy (RC) compared with standard RC in women who undergo curative surgery and orthotopic neobladder substitution for bladder cancer. BJU International, 120(1), 12–24. https://doi.org/10.1111/bju.13819.CrossRef

37.

Orvieto, M. A., DeCastro, G. J., Trinh, Q. D., Jeldres, C., Katz, M. H., Patel, V. R., et al. (2011). Oncological and functional outcomes after robot-assisted radical cystectomy: Critical review of current status. Urology, 78(5), 977–984. https://doi.org/10.1016/j.urology.2011.04.073.CrossRef

38.

Al-Tartir, T., Raza, S., Alotaibi, M., Khan, A., Hara, I., Fujisawa, M., et al. (2015). Robot-assisted surgical approach to bladder cancer: A decade of progress! Minerva Urologica E Nefrologica, 67(1), 55–63.

39.

Wilson, T. G., Guru, K., Rosen, R. C., Wiklund, P., Annerstedt, M., Bochner, B. H., et al. (2015). Best practices in robot-assisted radical cystectomy and urinary reconstruction: Recommendations of the pasadena consensus panel. European Urology, 67(3), 363–375. https://doi.org/10.1016/j.eururo.2014.12.009.CrossRef

40.

Tan, W. S., Khetrapal, P., Tan, W. P., Rodney, S., Chau, M., & Kelly, J. D. (2016). Robotic assisted radical cystectomy with extracorporeal urinary diversion does not show a benefit over open radical cystectomy: A systematic review and meta-analysis of randomised controlled trials. PLoS ONE. https://doi.org/10.1371/journal.pone.0166221.CrossRef

41.

Attalla, K., Kent, M., Waingankar, N., & Mehrazin, R. (2017). Robotic-assisted radical cystectomy versus open radical cystectomy for management of bladder cancer: Review of literature and randomized trials. Future Oncol, 13(13), 1195–1204. https://doi.org/10.2217/fon-2017-0004.CrossRef

42.

Lauridsen, S. V., Tonnesen, H., Jensen, B. T., Neuner, B., Thind, P., & Thomsen, T. (2017). Complications and health-related quality of life after robot-assisted versus open radical cystectomy: A systematic review and meta-analysis of four RCTs. Syst Rev, 6(1), 150. https://doi.org/10.1186/s13643-017-0547-y.CrossRef

43.

Lobo, N., Thurairaja, R., Nair, R., Dasgupta, P., & Khan, M. S. (2018). Robot-assisted radical cystectomy with intracorporeal urinary diversion—The new 'gold standard'? Evidence from a systematic review. Arab J Urol, 16(3), 307–313. https://doi.org/10.1016/j.aju.2018.01.006.CrossRef

44.

Rai, B. P., Bondad, J., Vasdev, N., Adshead, J., Lane, T., Ahmed, K., et al. (2019). Robotic versus open radical cystectomy for bladder cancer in adults. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.CD011903.pub2.CrossRef

45.

Kimura, S., Iwata, T., Foerster, B., Fossati, N., Briganti, A., Nasu, Y., et al. (2019). Comparison of perioperative complications and health-related quality of life between robot-assisted and open radical cystectomy: A systematic review and meta-analysis. International Journal of Urology, 26(8), 760–774.CrossRef

46.

Sathianathen, N. J., Kalapara, A., Frydenberg, M., Lawrentschuk, N., Weight, C. J., Parekh, D., et al. (2018). Robotic-assisted radical cystectomy vs open radical cystectomy: systematic review and meta-analysis. The Journal of Urology, 201(4), 715–720.CrossRef

47.

Perlis, N., Krahn, M., Alibhai, S., Finelli, A., Ritvo, P., Bremner, K. E., et al. (2014). Conceptualizing global health-related quality of life in bladder cancer. Quality of Life Research, 23(8), 2153–2167. https://doi.org/10.1007/s11136-014-0685-9.CrossRef

48.

Ploussard, G., Daneshmand, S., Efstathiou, J. A., Herr, H. W., James, N. D., Rodel, C. M., et al. (2014). Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer: A systematic review. European Urology, 66(1), 120–137. https://doi.org/10.1016/j.eururo.2014.02.038.CrossRef

49.

Feuerstein, M. A., & Goenka, A. (2015). Quality of life outcomes for bladder cancer patients undergoing bladder preservation with radiotherapy. Current Urology Reports, 16(11), 75. https://doi.org/10.1007/s11934-015-0547-1.CrossRef

50.

Taarnhoj, G. A., Johansen, C., & Pappot, H. (2019). Quality of life in bladder cancer patients receiving medical oncological treatment; a systematic review of the literature. Health Qual Life Outcomes, 17(1), 20. https://doi.org/10.1186/s12955-018-1077-6.CrossRef

51.

Shi, H., Yu, H., Bellmunt, J., Leow, J. J., Chen, X., Guo, C., et al. (2018). Comparison of health-related quality of life (HRQoL) between ileal conduit diversion and orthotopic neobladder based on validated questionnaires: a systematic review and meta-analysis. Quality of Life Research, 27(11), 2759–2775. https://doi.org/10.1007/s11136-018-1902-8.CrossRef

52.

Ziouziou, I., Irani, J., Wei, J. T., Karmouni, T., El Khader, K., Koutani, A., et al. (2018). Ileal conduit vs orthotopic neobladder: Which one offers the best health-related quality of life in patients undergoing radical cystectomy? A systematic review of literature and meta-analysis. Progres en Urologie, 28(5), 241–250. https://doi.org/10.1016/j.purol.2018.02.001.CrossRef

53.

Somani, B. K., MacLennan, S. J., & N'Dow, J. (2010). Quality of life with urinary diversion. European Urology, Supplements, 9(10), 763–771. https://doi.org/10.1016/j.eursup.2010.09.002.CrossRef

54.

Yang, L. S., Shan, B. L., Shan, L. L., Chin, P., Murray, S., Ahmadi, N., et al. (2016). A systematic review and meta-analysis of quality of life outcomes after radical cystectomy for bladder cancer. Surgical Oncology-Oxford, 25(3), 281–297. https://doi.org/10.1016/j.suronc.2016.05.027.CrossRef

55.

Desai, M. M., & Gill, I. S. J. E. U. (2015). The devil is in the details": Randomized trial of robotic versus open radical cystectomy. European Urology, 67(6), 1053–1055.CrossRef

56.

Catto, J. W., Khetrapal, P., Ambler, G., Sarpong, R., Khan, M. S., Tan, M., et al. (2018). Robot-assisted radical cystectomy with intracorporeal urinary diversion versus open radical cystectomy (iROC): Protocol for a randomised controlled trial with internal feasibility study. British Medical Journal Open, 8(8), e020500.

57.

Kretschmer, A., Grimm, T., Buchner, A., Stief, C. G., & Karl, A. (2016). Prognostic features for quality of life after radical cystectomy and orthotopic neobladder. International Brazilian Journal of Urology: Official Journal of the Brazilian Society of Urology, 42(6), 1109–1120. https://doi.org/10.1590/S1677-5538.IBJU.2015.0491.CrossRef

58.

Zhang, S., Yu, Y. H., Zhang, Y., Qu, W., & Li, J. (2015). Radiotherapy in muscle-invasive bladder cancer: The latest research progress and clinical application. American Journal of Cancer Research, 5(2), 854–868.

59.

Singer, S., Ziegler, C., Schwalenberg, T., Hinz, A., Gotze, H., & Schulte, T. (2013). Quality of life in patients with muscle invasive and non-muscle invasive bladder cancer. Supportive Care in Cancer, 21(5), 1383–1393. https://doi.org/10.1007/s00520-012-1680-8.CrossRef

60.

Van Hemelrijck, M., Sparano, F., Josephs, D., Sprangers, M., Cottone, F., & Efficace, F. (2019). Patient-reported outcomes in randomised clinical trials of bladder cancer: An updated systematic review. BMC Urology, 19(1), 86.CrossRef

61.

Boormans, J. L., & Zwarthoff, E. C. J. B. C. (2016). Limited funds for bladder cancer research and what can we do about it. Bladder Cancer, 2(1), 49–51.CrossRef

62.

Aluwini, S., Liem, E., Boormans, J., Antonisse, I., Praag, J. O., Kirkels, W., et al. (2015). Long-term treatment outcome of local recurrences after bladder preservation with brachytherapy for bladder carcinoma. International Journal of Radiation Oncology Biology Physics, 93(3), E216–E217.CrossRef

Titel: Health-related quality of life overview after different curative treatment options in muscle-invasive bladder cancer: an umbrella review
Auteurs: Elke Rammant
Lisa Van Wilder
Mieke Van Hemelrijck
Nele S. Pauwels
Karel Decaestecker
Charles Van Praet
Renée Bultijnck
Piet Ost
Thomas Van Vaerenbergh
Sofie Verhaeghe
Ann Van Hecke
Valérie Fonteyne
Publicatiedatum: 06-06-2020
Uitgeverij: Springer International Publishing
Gepubliceerd in: Quality of Life Research / Uitgave 11/2020
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-020-02544-z

Andere artikelen Uitgave 11/2020

Using qualitative methods for a conceptual analysis of measures of health status and presenteeism prior to a mapping study

Open Access

Trend in health-related quality of life and health utility and their decrements due to non-communicable diseases and risk factors: analysis of four population-based surveys between 1998 and 2015

Health-related quality of life and physical activity level after a behavior change program at Norwegian healthy life centers: a 15-month follow-up

Open Access

The association between self-reported health status and adverse events: a comparison among coronary artery bypass grafting (CABG) versus percutaneous coronary intervention (PCI)

Health-related quality of life after injury: examining the roles of perceived daily-life stress and injury perceptions

Known-groups validity and responsiveness to change of the Patient Experience with Treatment and Self-management (PETS vs. 2.0): a patient-reported measure of treatment burden